HKU State Key Laboratory for Emerging Infectious Diseases co-developed
COVID-19 vaccine candidate approved for clinical trial in humans
Description
The State Key Laboratory for Emerging Infectious Diseases of the University of Hong Kong (the SKL) has partnered with Xiamen University and Wantai Biopharmaceutical company to rapidly develop a vaccine candidate against COVID-19.
Resource Type
Addition Details
Date:
2020-09-09
Wave of COVID:
3rd
Category:
Source URL:
Share